查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1360314

細胞分析市場中基於影像的細胞儀 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Image Based Cytometry in Cell Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 179 Pages | 商品交期: 2-10個工作天內

價格

細胞分析市場中基於圖像的細胞計數 - 報告範圍

TMR 關於細胞分析市場中基於影像的細胞計數技術的全球報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球2017-2031年細胞分析市場以影像為基礎的細胞儀，考慮2023 年為基準年，2031 年為預測年。該報告也提供了2023年至2031年全球基於影像的細胞分析市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解細胞分析市場中基於圖像的細胞計數技術。

市場概況
2023年市場價值 27億美元
2031 年市場價值 65 億美元
年複合成長率 10.4%

該報告深入探討了細胞分析市場中基於影像的細胞計數技術的全球競爭格局。細胞分析市場中基於圖像的細胞計數技術的全球主要參與者已經被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概述、財務狀況、最新發展和 SWOT 是本報告中介紹的全球基於圖像的細胞分析市場參與者的屬性。

目錄

第 1 章：前言

第 2 章：假設與研究方法

第 3 章：市場概覽

  • 概述
  • 市場動態

第 4 章：全球基於圖像的細胞分析市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 生技與製藥公司
    • 學術界
    • 化妝品產業
    • 合約研究組織
    • 合約開發和製造組織

第 5 章：全球市場分析與預測：按治療領域

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依治療領域，2015-2031
    • 腫瘤學和免疫腫瘤學
      • 小分子
      • 以蛋白質為基礎的治療
      • 細胞療法
      • 核酸類藥物
    • 心血管及代謝疾病
      • 小分子
      • 以蛋白質為基礎的治療
      • 細胞療法
      • 核酸類藥物
    • 免疫學
      • 小分子
      • 以蛋白質為基礎的治療
      • 細胞療法
      • 核酸類藥物
    • 罕見疾病
      • 小分子
      • 以蛋白質為基礎的治療
      • 細胞療法
      • 核酸類藥物
    • 神經系統疾病
      • 小分子
      • 以蛋白質為基礎的治療
      • 細胞療法
      • 核酸類藥物
    • 其他
      • 小分子
      • 以蛋白質為基礎的治療
      • 細胞療法
      • 核酸類藥物

第 6 章：全球市場分析與預測：按工作場所

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依工作場所分類，2016-2031
    • 目標識別
    • 命中生成和線索識別
    • 潛在客戶最佳化
    • 體外臨床前研究
    • 體內臨床前研究
    • 臨床研究

第 7 章：全球市場分析與預測：按國家分類

  • 主要發現
  • 市場價值預測：依國家分類，2017-2031
    • 美國
    • 歐洲
    • 中國
    • 世界其他地區

第 8 章：美國基於影像的細胞分析技術市場分析與預測

第 9 章：歐洲基於影像的細胞分析技術市場分析與預測

第 10 章：中國細胞分析中基於影像的細胞計數市場分析與預測

第 11 章：世界其他地區細胞分析中基於影像的細胞計數市場分析和預測

第 12 章：競爭格局

  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • Nanolive SA
    • PerkinElmer, Inc.
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Charles River Laboratories
    • Yokogawa Electric Corporation
    • Carl Zeiss AG
Product Code: TMRGL85803

Image Based Cytometry in Cell Analysis Market - Scope of Report

TMR's report on the global image based cytometry in cell analysis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global image based cytometry in cell analysis market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global image based cytometry in cell analysis market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the image based cytometry in cell analysis market.

Market Snapshot
Market Value in 2023US$ 2.7 Bn
Market Value in 2031US$ 6.5 Bn
CAGR10.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global image based cytometry in cell analysis market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global image based cytometry in cell analysis market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global image based cytometry in cell analysis market.

The report delves into the competitive landscape of the global image based cytometry in cell analysis market. Key players operating in the global image based cytometry in cell analysis market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global image based cytometry in cell analysis market profiled in this report.

Key Questions Answered in Global Image Based Cytometry in Cell Analysis Market Report:

  • What is the sales/revenue generated by image based cytometry in cell analysis across all regions during the forecast period?
  • What are the opportunities in the global image based cytometry in cell analysis market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Image Based Cytometry in Cell Analysis Market - Research Objectives and Research Approach

The comprehensive report on the global image based cytometry in cell analysis market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global image based cytometry in cell analysis market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global image based cytometry in cell analysis market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Key Research Objectives

2. Assumptions and Research Methodology

3. Market Overview

  • 3.1. Overview
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities

4. Global Image-based Cytometry in Cell Analysis Market Analysis and Forecast, by End-user

  • 4.1. Introduction & Definition
  • 4.2. Key Findings/Developments
  • 4.3. Market Value Forecast, by End-user, 2017-2031
    • 4.3.1. Biotechnology & Pharmaceutical Companies
    • 4.3.2. Academia
    • 4.3.3. Cosmetic Industry
    • 4.3.4. Contract Research Organizations
    • 4.3.5. Contract Development & Manufacturing Organizations

5. Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Analysis and Forecast, by Therapeutic Area

  • 5.1. Introduction & Definition
  • 5.2. Key Findings/Developments
  • 5.3. Market Value Forecast, by Therapeutic Area, 2015-2031
    • 5.3.1. Oncology & Immune-oncology
      • 5.3.1.1. Small Molecules
      • 5.3.1.2. Protein-based Therapeutics
      • 5.3.1.3. Cell Therapy
      • 5.3.1.4. Nucleic Acid-based Drugs
    • 5.3.2. Cardiovascular & Metabolic Diseases
      • 5.3.2.1. Small Molecules
      • 5.3.2.2. Protein-based Therapeutics
      • 5.3.2.3. Cell Therapy
      • 5.3.2.4. Nucleic Acid-based Drugs
    • 5.3.3. Immunology
      • 5.3.3.1. Small Molecules
      • 5.3.3.2. Protein-based Therapeutics
      • 5.3.3.3. Cell Therapy
      • 5.3.3.4. Nucleic Acid-based Drugs
    • 5.3.4. Rare Diseases
      • 5.3.4.1. Small Molecules
      • 5.3.4.2. Protein-based Therapeutics
      • 5.3.4.3. Cell Therapy
      • 5.3.4.4. Nucleic Acid-based Drugs
    • 5.3.5. Neurological Diseases
      • 5.3.5.1. Small Molecules
      • 5.3.5.2. Protein-based Therapeutics
      • 5.3.5.3. Cell Therapy
      • 5.3.5.4. Nucleic Acid-based Drugs
    • 5.3.6. Others
      • 5.3.6.1. Small Molecules
      • 5.3.6.2. Protein-based Therapeutics
      • 5.3.6.3. Cell Therapy
      • 5.3.6.4. Nucleic Acid-based Drugs

6. Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Analysis and Forecast, by Workplace

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Workplace, 2016-2031
    • 6.3.1. Target Identification
    • 6.3.2. Hit Generation & Lead Identification
    • 6.3.3. Lead Optimization
    • 6.3.4. In Vitro Preclinical Studies
    • 6.3.5. In Vivo Preclinical Studies
    • 6.3.6. Clinical Studies

7. Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Analysis and Forecast, by Country/Region

  • 7.1. Key Findings
  • 7.2. Market Value Forecast, by Country/Region, 2017-2031
    • 7.2.1. U.S.
    • 7.2.2. Europe
    • 7.2.3. China
    • 7.2.4. Rest of the World

8. U.S. Image-based Cytometry in Cell Analysis Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Findings
  • 8.2. Market Value Forecast, by End-user, 2017-2031
    • 8.2.1. Biotechnology & Pharmaceutical Companies
    • 8.2.2. Academia
    • 8.2.3. Cosmetic Industry
    • 8.2.4. Contract Research Organizations
    • 8.2.5. Contract Development & Manufacturing Organizations
  • 8.3. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Therapeutic Area, 2017-2031
    • 8.3.1. Oncology & Immune-oncology
      • 8.3.1.1. Small Molecules
      • 8.3.1.2. Protein-based Therapeutics
      • 8.3.1.3. Cell Therapy
      • 8.3.1.4. Nucleic Acid-based Drugs
    • 8.3.2. Cardiovascular & Metabolic Diseases
      • 8.3.2.1. Small Molecules
      • 8.3.2.2. Protein-based Therapeutics
      • 8.3.2.3. Cell Therapy
      • 8.3.2.4. Nucleic Acid-based Drugs
    • 8.3.3. Immunology
      • 8.3.3.1. Small Molecules
      • 8.3.3.2. Protein-based Therapeutics
      • 8.3.3.3. Cell Therapy
      • 8.3.3.4. Nucleic Acid-based Drugs
    • 8.3.4. Rare Diseases
      • 8.3.4.1. Small Molecules
      • 8.3.4.2. Protein-based Therapeutics
      • 8.3.4.3. Cell Therapy
      • 8.3.4.4. Nucleic Acid-based Drugs
    • 8.3.5. Neurological Diseases
      • 8.3.5.1. Small Molecules
      • 8.3.5.2. Protein-based Therapeutics
      • 8.3.5.3. Cell Therapy
      • 8.3.5.4. Nucleic Acid-based Drugs
    • 8.3.6. Others
      • 8.3.6.1. Small Molecules
      • 8.3.6.2. Protein-based Therapeutics
      • 8.3.6.3. Cell Therapy
      • 8.3.6.4. Nucleic Acid-based Drugs
  • 8.4. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Workplace, 2017-2031
    • 8.4.1. Target Identification
    • 8.4.2. Hit Generation & Lead Identification
    • 8.4.3. Lead Optimization
    • 8.4.4. In Vitro Preclinical Studies
    • 8.4.5. In Vivo Preclinical Studies
    • 8.4.6. Clinical Studies

9. Europe Image-based Cytometry in Cell Analysis Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by End-user, 2017-2031
    • 9.2.1. Biotechnology & Pharmaceutical Companies
    • 9.2.2. Academia
    • 9.2.3. Cosmetic Industry
    • 9.2.4. Contract Research Organizations
    • 9.2.5. Contract Development & Manufacturing Organizations
  • 9.3. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Therapeutic Area, 2017-2031
    • 9.3.1. Oncology & Immune-oncology
      • 9.3.1.1. Small Molecules
      • 9.3.1.2. Protein-based Therapeutics
      • 9.3.1.3. Cell Therapy
      • 9.3.1.4. Nucleic Acid-based Drugs
    • 9.3.2. Cardiovascular & Metabolic Diseases
      • 9.3.2.1. Small Molecules
      • 9.3.2.2. Protein-based Therapeutics
      • 9.3.2.3. Cell Therapy
      • 9.3.2.4. Nucleic Acid-based Drugs
    • 9.3.3. Immunology
      • 9.3.3.1. Small Molecules
      • 9.3.3.2. Protein-based Therapeutics
      • 9.3.3.3. Cell Therapy
      • 9.3.3.4. Nucleic Acid-based Drugs
    • 9.3.4. Rare Diseases
      • 9.3.4.1. Small Molecules
      • 9.3.4.2. Protein-based Therapeutics
      • 9.3.4.3. Cell Therapy
      • 9.3.4.4. Nucleic Acid-based Drugs
    • 9.3.5. Neurological Diseases
      • 9.3.5.1. Small Molecules
      • 9.3.5.2. Protein-based Therapeutics
      • 9.3.5.3. Cell Therapy
      • 9.3.5.4. Nucleic Acid-based Drugs
    • 9.3.6. Others
      • 9.3.6.1. Small Molecules
      • 9.3.6.2. Protein-based Therapeutics
      • 9.3.6.3. Cell Therapy
      • 9.3.6.4. Nucleic Acid-based Drugs
  • 9.4. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Workplace, 2017-2031
    • 9.4.1. Target Identification
    • 9.4.2. Hit Generation & Lead Identification
    • 9.4.3. Lead Optimization
    • 9.4.4. In Vitro Preclinical Studies
    • 9.4.5. In Vivo Preclinical Studies
    • 9.4.6. Clinical Studies
  • 9.5. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Country/Sub-region, 2017-2031
    • 9.5.1. EU5
    • 9.5.2. U.K.
    • 9.5.3. Switzerland
    • 9.5.4. Rest of Europe

10. China Image-based Cytometry in Cell Analysis Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by End-user, 2017-2031
    • 10.2.1. Biotechnology & Pharmaceutical Companies
    • 10.2.2. Academia
    • 10.2.3. Cosmetic Industry
    • 10.2.4. Contract Research Organizations
    • 10.2.5. Contract Development & Manufacturing Organizations
  • 10.3. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Therapeutic Area, 2017-2031
    • 10.3.1. Oncology & Immune-oncology
      • 10.3.1.1. Small Molecules
      • 10.3.1.2. Protein-based Therapeutics
      • 10.3.1.3. Cell Therapy
      • 10.3.1.4. Nucleic Acid-based Drugs
    • 10.3.2. Cardiovascular & Metabolic Diseases
      • 10.3.2.1. Small Molecules
      • 10.3.2.2. Protein-based Therapeutics
      • 10.3.2.3. Cell Therapy
      • 10.3.2.4. Nucleic Acid-based Drugs
    • 10.3.3. Immunology
      • 10.3.3.1. Small Molecules
      • 10.3.3.2. Protein-based Therapeutics
      • 10.3.3.3. Cell Therapy
      • 10.3.3.4. Nucleic Acid-based Drugs
      • 10.3.3.5. Nucleic Acid
    • 10.3.4. Rare Diseases
      • 10.3.4.1. Small Molecules
      • 10.3.4.2. Protein-based Therapeutics
      • 10.3.4.3. Cell Therapy
      • 10.3.4.4. Nucleic Acid-based Drugs
    • 10.3.5. Neurological Diseases
      • 10.3.5.1. Small Molecules
      • 10.3.5.2. Protein-based Therapeutics
      • 10.3.5.3. Cell Therapy
      • 10.3.5.4. Nucleic Acid-based Drugs
    • 10.3.6. Others
      • 10.3.6.1. Small Molecules
      • 10.3.6.2. Protein-based Therapeutics
      • 10.3.6.3. Cell Therapy
      • 10.3.6.4. Nucleic Acid-based Drugs
  • 10.4. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Workplace, 2017-2031
    • 10.4.1. Target Identification
    • 10.4.2. Hit Generation & Lead Identification
    • 10.4.3. Lead Optimization
    • 10.4.4. In Vitro Preclinical Studies
    • 10.4.5. In Vivo Preclinical Studies
    • 10.4.6. Clinical Studies

11. Rest of the World Image-based Cytometry in Cell Analysis Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by End-user, 2017-2031
    • 11.2.1. Biotechnology & Pharmaceutical Companies
    • 11.2.2. Academia
    • 11.2.3. Cosmetic Industry
    • 11.2.4. Contract Research Organizations
    • 11.2.5. Contract Development & Manufacturing Organizations
  • 11.3. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Therapeutic Area, 2017-2031
    • 11.3.1. Oncology & Immune-oncology
      • 11.3.1.1. Small Molecules
      • 11.3.1.2. Protein-based Therapeutics
      • 11.3.1.3. Cell Therapy
      • 11.3.1.4. Nucleic Acid-based Drugs
    • 11.3.2. Cardiovascular & Metabolic Diseases
      • 11.3.2.1. Small Molecules
      • 11.3.2.2. Protein-based Therapeutics
      • 11.3.2.3. Cell Therapy
      • 11.3.2.4. Nucleic Acid-based Drugs
    • 11.3.3. Immunology
      • 11.3.3.1. Small Molecules
      • 11.3.3.2. Protein-based Therapeutics
      • 11.3.3.3. Cell Therapy
      • 11.3.3.4. Nucleic Acid-based Drugs
    • 11.3.4. Rare Diseases
      • 11.3.4.1. Small Molecules
      • 11.3.4.2. Protein-based Therapeutics
      • 11.3.4.3. Cell Therapy
      • 11.3.4.4. Nucleic Acid-based Drugs
    • 11.3.5. Neurological Diseases
      • 11.3.5.1. Small Molecules
      • 11.3.5.2. Protein-based Therapeutics
      • 11.3.5.3. Cell Therapy
      • 11.3.5.4. Nucleic Acid-based Drugs
    • 11.3.6. Others
      • 11.3.6.1. Small Molecules
      • 11.3.6.2. Protein-based Therapeutics
      • 11.3.6.3. Cell Therapy
      • 11.3.6.4. Nucleic Acid-based Drugs
  • 11.4. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Workplace, 2017-2031
    • 11.4.1. Target Identification
    • 11.4.2. Hit Generation & Lead Identification
    • 11.4.3. Lead Optimization
    • 11.4.4. In Vitro Preclinical Studies
    • 11.4.5. In Vivo Preclinical Studies
    • 11.4.6. Clinical Studies

12. Competition Landscape

  • 12.1. Market Share Analysis, by Company (2022)
  • 12.2. Company Profiles
    • 12.2.1. Nanolive SA
      • 12.2.1.1. Company Overview
      • 12.2.1.2. Product Portfolio/Brands with its Description/Features
      • 12.2.1.3. Strategic Overview/Recent Developments
      • 12.2.1.4. SWOT Analysis
    • 12.2.2. PerkinElmer, Inc.
      • 12.2.2.1. Company Overview
      • 12.2.2.2. Product Portfolio/Brands with its Description/Features
      • 12.2.2.3. Financial Overview
      • 12.2.2.4. Strategic Overview/Recent Developments
      • 12.2.2.5. SWOT Analysis
    • 12.2.3. Sartorius AG
      • 12.2.3.1. Company Overview
      • 12.2.3.2. Product Portfolio/Brands with its Description/Features
      • 12.2.3.3. Financial Overview
      • 12.2.3.4. Strategic Overview/Recent Developments
      • 12.2.3.5. SWOT Analysis
    • 12.2.4. Thermo Fisher Scientific Inc.
      • 12.2.4.1. Company Overview
      • 12.2.4.2. Product Portfolio/Brands with its Description/Features
      • 12.2.4.3. Financial Overview
      • 12.2.4.4. Strategic Overview/Recent Developments
      • 12.2.4.5. SWOT Analysis
    • 12.2.5. Merck KGaA
      • 12.2.5.1. Company Overview
      • 12.2.5.2. Product Portfolio/Brands with its Description/Features
      • 12.2.5.3. Financial Overview
      • 12.2.5.4. Strategic Overview/Recent Developments
      • 12.2.5.5. SWOT Analysis
    • 12.2.6. Charles River Laboratories
      • 12.2.6.1. Company Overview
      • 12.2.6.2. Product Portfolio/Brands with its Description/Features
      • 12.2.6.3. Financial Overview
      • 12.2.6.4. SWOT Analysis
    • 12.2.7. Yokogawa Electric Corporation
      • 12.2.7.1. Company Overview
      • 12.2.7.2. Product Portfolio/Brands with its Description/Features
      • 12.2.7.3. Financial Overview
      • 12.2.7.4. SWOT Analysis
    • 12.2.8. Carl Zeiss AG
      • 12.2.8.1. Company Overview
      • 12.2.8.2. Product Portfolio/Brands with its Description/Features
      • 12.2.8.3. Financial Overview
      • 12.2.8.4. Strategic Overview/Recent Developments
      • 12.2.8.5. SWOT Analysis

List of Tables

  • Table 01: Global Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 02: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031
  • Table 03: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Oncology & Immune-oncology, 2017-2031
  • Table 04: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Cardiovascular & Metabolic Diseases, 2017-2031
  • Table 05: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Immunology, 2017-2031
  • Table 06: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Rare Diseases, 2017-2031
  • Table 07: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Neurological Diseases, 2017-2031
  • Table 08: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Others, 2017-2031
  • Table 09: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Workplace, 2017-2031
  • Table 10: Global Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 11: U.S. Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031
  • Table 13: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Oncology & Immune-oncology, 2017-2031
  • Table 14: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Cardiovascular & Metabolic Diseases, 2017-2031
  • Table 15: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Immunology, 2017-2031
  • Table 16: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Rare Diseases, 2017-2031
  • Table 17: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Neurological Diseases, 2017-2031
  • Table 18: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Others, 2017-2031
  • Table 19: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Workplace, 2017-2031
  • Table 20: Europe Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031
  • Table 22: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Oncology & Immune-oncology, 2017-2031
  • Table 23: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Cardiovascular & Metabolic Diseases, 2017-2031
  • Table 24: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Immunology, 2017-2031
  • Table 25: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Rare Diseases, 2017-2031
  • Table 26: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Neurological Diseases, 2017-2031
  • Table 27: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Others, 2017-2031
  • Table 28: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Workplace, 2017-2031
  • Table 29: Europe Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 30: China Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031
  • Table 32: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Oncology & Immune-oncology, 2017-2031
  • Table 33: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Cardiovascular & Metabolic Diseases, 2017-2031
  • Table 34: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Immunology, 2017-2031
  • Table 35: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Rare Diseases, 2017-2031
  • Table 36: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Neurological Diseases, 2017-2031
  • Table 37: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Others, 2017-2031
  • Table 38: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Workplace, 2017-2031
  • Table 39: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 40: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031
  • Table 41: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Oncology & Immune-oncology, 2017-2031
  • Table 42: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Cardiovascular & Metabolic Diseases, 2017-2031
  • Table 43: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Immunology, 2017-2031
  • Table 44: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Rare Diseases, 2017-2031
  • Table 45: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Neurological Diseases, 2017-2031
  • Table 46: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Others, 2017-2031
  • Table 47: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Workplace, 2017-2031

List of Figures

  • Figure 01: Growth in Adoption of CyTOF in National Clinical Trials
  • Figure 02: National Clinical Trials Citing CyTOF Technology, by Research Area, 2022
  • Figure 03: Number of Clinical Trials, by Platform, 2022
  • Figure 04: Global Image-based Cytometry in Cell Analysis Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 05: Global Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 06: Global Image-based Cytometry in Cell Analysis Market (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2017-2031
  • Figure 07: Global Image-based Cytometry in Cell Analysis Market (US$ Mn), by Academia, 2017-2031
  • Figure 08: Global Image-based Cytometry in Cell Analysis Market (US$ Mn), by Cosmetic Industry, 2017-2031
  • Figure 09: Global Image-based Cytometry in Cell Analysis Market (US$ Mn), by Contract Research Organizations, 2017-2031
  • Figure 10: Global Image-based Cytometry in Cell Analysis Market (US$ Mn), by Contract Development & Manufacturing Organizations, 2017-2031
  • Figure 11: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
  • Figure 12: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by Therapeutic Area, 2023-2031
  • Figure 13: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market (US$ Mn), by Oncology & Immune-oncology, 2017-2031
  • Figure 14: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market (US$ Mn), by Cardiovascular & Metabolic Diseases, 2017-2031
  • Figure 15: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market (US$ Mn), by Immunology, 2017-2031
  • Figure 16: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market (US$ Mn), by Rare Diseases, 2017-2031
  • Figure 17: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market (US$ Mn), by Neurological Diseases, 2017-2031
  • Figure 18: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market (US$ Mn), by Others, 2017-2031
  • Figure 19: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Analysis and Forecast, by Workplace, 2022 and 2031
  • Figure 20: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by Workplace, 2023-2031
  • Figure 21: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market (US$ Mn), by Target Identification, 2017-2031
  • Figure 22: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market (US$ Mn), by Hit Generation & Lead Identification, 2017-2031
  • Figure 23: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market (US$ Mn), by Lead Optimization, 2017-2031
  • Figure 24: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market (US$ Mn), by In Vitro Preclinical Studies, 2017-2031
  • Figure 25: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market (US$ Mn), by In Vivo Preclinical Studies, 2017-2031
  • Figure 26: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market (US$ Mn), by Clinical Studies, 2017-2031
  • Figure 27: Global Image-based Cytometry in Cell Analysis Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 28: Global Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 29: U.S. Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 30: U.S. Image-based Cytometry in Cell Analysis Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 31: U.S. Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 32: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
  • Figure 33: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by Therapeutic Area, 2023-2031
  • Figure 34: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value Share Analysis, by Workplace, 2022 and 2031
  • Figure 35: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by Workplace, 2023-2031
  • Figure 36: Europe Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 37: Europe Image-based Cytometry in Cell Analysis Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 38: Europe Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 39: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
  • Figure 40: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by Therapeutic Area, 2023-2031
  • Figure 41: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value Share Analysis, by Workplace, 2022 and 2031
  • Figure 42: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by Workplace, 2023-2031
  • Figure 43: Europe Image-based Cytometry in Cell Analysis Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 44: Europe Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 45: China Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 46: China Image-based Cytometry in Cell Analysis Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 47: China Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 48: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
  • Figure 49: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by Therapeutic Area, 2023-2031
  • Figure 50: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value Share Analysis, by Workplace, 2022 and 2031
  • Figure 51: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by Workplace, 2023-2031
  • Figure 52: Rest of the World Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 53: Rest of the World Image-based Cytometry in Cell Analysis Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 54: Rest of the World Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 55: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
  • Figure 56: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by Therapeutic Area, 2023-2031
  • Figure 57: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value Share Analysis, by Workplace, 2022 and 2031
  • Figure 58: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Attractiveness Analysis, by Workplace, 2023-2031
  • Figure 59: Global Image-based Cytometry in Cell Analysis Market Share Analysis, by Company, 2022